Gynecologic Neoplasms Clinical Trial
Official title:
Regular Versus Liquid Diet as the First Meal in Patients Undergoing Major Abdominal Gynecologic Cancer Operation: A Randomized Controlled Trial
Verified date | June 2011 |
Source | Chiang Mai University |
Contact | n/a |
Is FDA regulated | No |
Health authority | Thailand: Ethical Committee |
Study type | Interventional |
The purpose of this study is to determine whether it is safe to give a regular diet as the first postoperative meal in patients who underwent surgical treatment for clinically early-stage gynecologic cancer.
Status | Withdrawn |
Enrollment | 240 |
Est. completion date | April 2007 |
Est. primary completion date | |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 75 Years |
Eligibility |
Inclusion Criteria: - Clinically early-stage gynecologic cancer patients who underwent standard abdominal surgery as a primary treatment of their diseases Exclusion Criteria: - Peritonitis - Perioperative hyperalimentation - Bowel surgery (except appendectomy) - Bowel obstruction - History of bowel surgery or inflammatory bowel syndromes - History of abdominal/pelvic radiotherapy - Need for continued postoperative endotracheal tube or naso/orogastric tube placement - Need for postoperative Intensive Care Unit (ICU) administration - Pregnancy |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Thailand | Department of OB-GYN, Faculty of Medicine, Chiang Mai University | Muang Chiangmai | Chiang Mai |
Lead Sponsor | Collaborator |
---|---|
Chiang Mai University |
Thailand,
Jeffery KM, Harkins B, Cresci GA, Martindale RG. The clear liquid diet is no longer a necessity in the routine postoperative management of surgical patients. Am Surg. 1996 Mar;62(3):167-70. — View Citation
MacMillan SL, Kammerer-Doak D, Rogers RG, Parker KM. Early feeding and the incidence of gastrointestinal symptoms after major gynecologic surgery. Obstet Gynecol. 2000 Oct;96(4):604-8. — View Citation
Patolia DS, Hilliard RL, Toy EC, Baker B. Early feeding after cesarean: randomized trial. Obstet Gynecol. 2001 Jul;98(1):113-6. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Rate of clinically significant postoperative ileus | |||
Secondary | Patient's satisfaction | |||
Secondary | Other postoperative complications | |||
Secondary | Time to first flatus | |||
Secondary | Amount of meal taken | |||
Secondary | Hospital stay |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02653469 -
Augmented Pulse Pressure Variation to Predict Fluid Responsiveness in Open Laparotomy
|
N/A | |
Recruiting |
NCT05185947 -
Study of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis From Colorectal, Appendiceal, Small Bowel, Gastric, Cholangiocarcinoma, Breast, Ovarian, or Other Gynecologic Primary Cancer
|
Phase 2 | |
Completed |
NCT02309944 -
Negative Pressure Wound Therapy in Obese Gynecologic Oncology Patients
|
N/A | |
Completed |
NCT02728830 -
A Study of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers
|
Early Phase 1 | |
Completed |
NCT02935530 -
Thromboprophylaxis After Surgery for Gynecologic Malignancy in China
|
Phase 3 | |
Completed |
NCT02918461 -
Emerging From the Haze for Gynecologic Cancer Survivors
|
N/A | |
Completed |
NCT02786524 -
Effect of Outpatient Symptom Management on Gynecologic Oncology Patients Receiving Chemotherapy
|
N/A | |
Terminated |
NCT04493619 -
PLX2853 as a Single Agent in Advanced Gynecological Malignancies and in Combination With Carboplatin in Platinum-Resistant Epithelial Ovarian Cancer
|
Phase 1/Phase 2 | |
Completed |
NCT03101280 -
A Combination Study of Rucaparib and Atezolizumab in Participants With Advanced Gynecologic Cancers and Triple-Negative Breast Cancer
|
Phase 1 |